Industrie

• Azzeramento di tutti ×
• Assistenza sanitaria & Scienze di vita ×
• Banca dati ×

Showing 51–60 Di 134 risultati

Ordina per popolarità Ordina per valutazione media Ordina per ultimo Ordina per prezzo: dal basso all'alto Ordina per prezzo: Dall'alto al basso

• 

  Non-small-cell Lung Carcinoma (NSCLC) Market in China

  At 3% CAGR, the non-small-cell lung carcinoma (NSCLC) market in China is projected to reach 967 thousand units by 2027, secondo la società di dati e analisi StrategyHelix.

  Dollaro statunitense 10
• 

  Nasopharyngeal Cancer Market in China

  According to a statistic by StrategyHelix, the nasopharyngeal cancer market in China, in terms of volume, is expected to expand at a CAGR of 1.2% in the next five years.

  Dollaro statunitense 5
• 

  Head and Neck Cancer Market in China

  The head and neck cancer market in China, in terms of volume, is expected to expand at a CAGR of 1.7% da 2021 Attraverso 2027, secondo la società di dati e analisi StrategyHelix.

  Dollaro statunitense 5
• 

  Global Immuno-Oncology Therapy Market

  The global immuno-oncology therapy market is expected to increase at a CAGR of 22.6% fino 2027, secondo la società di dati e analisi StrategyHelix.

  Dollaro statunitense 10
• 

  Oncology Drug Market in China

  The oncology drug market in China is poised to grow at a CAGR of around 13.3% nel periodo di analisi di 2021 A 2027, secondo la società di dati e analisi StrategyHelix.

  Dollaro statunitense 10
• 

  Global Oncology Drug Market

  According to a statistic by StrategyHelix, the global oncology drug market is poised to grow at a CAGR of around 12.6% nel periodo di analisi di 2021 A 2027.

  Dollaro statunitense 15
• 

  Biomedical Materials Market in China

  A statistic by StrategyHelix indicates that the biomedical materials market in China is expected to increase at a CAGR of 11.5% fino 2027.

  Dollaro statunitense 15
• 

  Home Use Medical Device Market in China

  The home use medical device market in China is set to increase by US$ 12,122 milioni da 2021 A 2027, che rappresenta un tasso di crescita annuale composto (CAGR) Di 10% durante il periodo di previsione.

  Dollaro statunitense 5
• 

  Blood Glucose Market in China

  The blood glucose market in China is poised to grow by US$ 18,136 milioni durante 2021-2027, procedendo a un CAGR di 22.8% durante il periodo di previsione, secondo la società di dati e analisi StrategyHelix.

  Dollaro statunitense 10
• 

  Nutritional Supplement Market in China

  The nutritional supplement market in China was around 233 m units in 2020, reached 272 m units in 2021 (an increase of 16.5% year-on-year), secondo StrategyHelix’ analysis.

  Dollaro statunitense 5